Pitfalls in immunofluorescence testing in dermatology. III. Pemphigus-like antibodies in the horse and direct immunofluorescence testing in equine dermatophilosis.

This research paper studies the risk of misinterpretation and misdiagnosis when using immunofluorescence testing for skin conditions in horses. It specifies that pemphigus-like antibodies in horses and equine dermatophilosis could potentially lead to incorrect diagnosis.

Study Design and Participants

• The study included thorough immunofluorescence testing on 79 horses, divided into various categories – 28 horses with different non-pemphigus skin diseases, 21 horses with various non-dermatological diseases, and 30 normal horses.
• Direct immunofluorescence testing for whole immunoglobulin, IgG, IgM, and IgA was conducted on skin lesions from 2 horses with dermatophilosis.

Findings

• The researchers found pemphigus-like antibodies in six horses: three normal horses with titers of 1:40, two horses with dermatophilosis at titers of 1:10 and 1:80, and one horse suffered from lymphosarcoma with a titer of 1:320.
• In both horses with dermatophilosis, researchers observed a diffuse intercellular deposition of whole immunoglobulin and IgG.

Conclusions

• The research concluded that the presence of pemphigus-like antibodies in horses can lead to misinterpretation and consequently, wrong diagnosis during indirect immunofluorescence testing.
• Additionally, equine dermatophilosis might also lead to incorrect interpretation and diagnosis when performing direct immunofluorescence testing.

Implications

• This study emphasizes potential issues in diagnostic practices for equine skin conditions using immunofluorescence testing due to the presence of pemphigus-like antibodies and dermatophilosis.
• The research highlights the importance of considering these factors when diagnosing and treating equine skin diseases. This will help avoid misdiagnoses and ensure effective treatment plans for affected horses.